Erratum: Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: New formulation and dosing regimen (Cerebrovascular Diseases (2013) 36 (196-204) DOI: 10.1159/000353680)

摘要

In the article by Kaste et al., entitled 'Safety, tolerability and pharmacokinetics of MCI -186 in patients with acute ischemic stroke: new formulation and dosing regimen' [Cere-brovasc Dis 2013;36:196-204, DOI: 10.1159/000353680], the following information was erroneously omitted: Steering Committee Markku Kaste, Turgut Tatlisumak, Helsinki University Central Hospital, Finland; Peter Koudstaal, Diederik Dippel, Erasmus Medical Center, Rotterdam, The Netherlands; Gary Ford, Newcastle University, UK. Data and Safety Monitoring Committee Kennedy Lees, Western Infirmary, Glasgow, UK; Philip Bath, University of Nottingham, UK.